TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter investor letter. A copy of the same can be downloaded here. In the ...
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which ...
For more than a decade, Dr. Molly Maloof has had a front-row seat to Silicon Valley’s ever-evolving health obsessions as a ...
Reata Pharmaceuticals (NASDAQ:RETA) stock is soaring higher on Friday as investors react to an acquisition deal with Biogen (NASDAQ:BIIB). That deal has Biogen offering to buy shares of RETA stock for ...
In recent trading, shares of Reata Pharmaceuticals Inc (Symbol: RETA) have crossed above the average analyst 12-month target price of $119.18, changing hands for $167.19/share. When a stock reaches ...
Reata Pharmaceuticals, Inc. (NASDAQ:RETA) shareholders should be happy to see the share price up 26% in the last month. But that hardly compensates for the shocking decline over the last twelve months ...
Reta Mays, a 46-year-old nursing assistant and a US Army veteran, caused the deaths of seven elderly male veterans and assaulted another one. Mays, who was not licensed to dispense medications, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results